Carlos Campoy
2022
In 2022, Carlos Campoy earned a total compensation of $1.4M as Former Senior Vice President and Chief Financial Officer at CytomX Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Option Awards | $330,723 |
|---|---|
| Salary | $349,479 |
| Stock Awards | $92,925 |
| Other | $647,144 |
| Total | $1,420,271 |
Campoy received $647.1K in other compensation, accounting for 46% of the total pay in 2022.
Campoy also received $330.7K in option awards, $349.5K in salary and $92.9K in stock awards.
Rankings
In 2022, Carlos Campoy's compensation ranked 2,345th out of 5,753 executives tracked by ExecPay. In other words, Campoy earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,345 out of 5,753 | 59th |
Division Manufacturing | 1,278 out of 3,133 | 59th |
Major group Chemicals And Allied Products | 570 out of 1,419 | 60th |
Industry group Drugs | 525 out of 1,320 | 60th |
Industry Pharmaceutical Preparations | 379 out of 966 | 61st |
Source: SEC filing on April 27, 2023.
Campoy's colleagues
We found four more compensation records of executives who worked with Carlos Campoy at CytomX Therapeutics in 2022.